← Leaderboards
Carlos Jesus Perez Kerkvliet
University Of Minnesota
$151,572
Attributed
$151,572
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$151,572 · 1
By mechanism
F30$151,572 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Carol Ann Lange$17,870,830
- Douglas Yee$35,505,227
- Julie H Ostrander$1,836,395
- Carol Ann Sartorius$5,515,814
- David J Odde$19,147,767
Others in their field
Other Emerging Leaders on “Advanced Breast Cancer”
- Greg Yothers · University Of Chicago$35,003,821
- Christoph I Lee · University Of Washington$7,678,867
- Mara Becker · Duke University$6,798,777
- Birgit Schilling · Medical College Of Wisconsin$6,020,375
- Julie E Bauman · University Of Arizona$5,298,647
- Allison Payne · Utah State Higher Education System--University Of Utah$4,858,409
Research focus
Advanced Breast CancerAdvanced Malignant NeoplasmAntigensBaseBehaviorBiological MarkersBiologyBreast Cancer CellBreast Cancer Cell LineBreast Cancer MetastasisBreast Cancer ModelBreast Cancer PatientBreast Cancer ProgressionCancer BiologyCancer CellCancer SubtypesCell MotilityCell SurvivalCellular StressCofactorComplexComputational BiologyCytokineAccounting
Grant awards (3)
PhosphoSer134 GR, TGF-β and 14-3-3-zeta cooperate to promote progression of Triple Negative Breast Cancer$51,036
F30 · FY2021 · CA · contact PI
PhosphoSer134 GR, TGF-β and 14-3-3-zeta cooperate to promote progression of Triple Negative Breast Cancer$50,520
F30 · FY2020 · CA · contact PI
PhosphoSer134 GR, TGF-β and 14-3-3-zeta cooperate to promote progression of Triple Negative Breast Cancer$50,016
F30 · FY2019 · CA · contact PI